Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurologic Symptoms After Non-severe COVID-19 : Analysis and Diagnosis Assessment of Somatic Spectrum Disorder

NCT04889313 is registered in ClinicalTrials.gov with Centre Hospitalier de Saint-Denis as lead sponsor.

NCT NCT04889313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04889313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurologic Symptoms After Non-severe COVID-19 : Analysis and Diagnosis Assessment of Somatic Spectrum Disorder
Lead sponsor
Centre Hospitalier de Saint-Denis
Phase
Observational
Overall status
Completed
Start date
April 22, 2021
Completion date
October 30, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19